Diagnóstico y tratamiento | 04 NOV 18

Miocardiopatía inducida por estrés

Enfoque práctico para el diagnóstico y tratamiento de pacientes con miocardiopatía de estrés, donde se destacan los desafíos potenciales y los interrogantes no resueltos
Autor/a: Medina de Chazal H, Del Buono MG, Keyser-Marcus L et al J Am Coll Cardiol 2018;72:1955–71 2018
INDICE:  1. Página 1 | 2. Referencias bibliográficas
Referencias bibliográficas

1. Sato H, Tateishi H, Dote K, et al. Tako-tsubo like left ventricular dysfunction due to multivessel coronary spasm. In: Kodama K, Haze K, Hori M, editors. Clinical Aspects of Myocardial Injury: From Ischemia to Heart Failure. Tokyo: Tokio Kagakuhyoronsha Publ Co., 1990:56–64.

2. Hurst RT, Prasad A, Askew JW, Sengupta PP, Tajik AJ. Takotsubo cardiomyopathy: a unique cardiomyopathy with variable ventricular morphology. J Am Coll Cardiol Img 2010;3:641–9.

3. Medeiros K, O’Connor MJ, Baicu CF, et al. Systolic and diastolic mechanics in stress cardiomyopathy. Circulation 2014;129:1659–67.

4. Kurisu S, Sato H, Kawagoe T, et al. Tako-tsubo–like left ventricular dysfunction with ST-segment elevation: a novel cardiac syndrome mimicking acute myocardial infarction. Am Heart J 2002;143:448–55.

5. Gianni M, Dentali F, Grandi AM, Sumner G, Hiralal R, Lonn E. Apical ballooning syndrome or takotsubo cardiomyopathy: a systematic review. Eur Heart J 2006;27:1523–9.

6. Kurowski V, Kaiser A, Von Hof K, et al. Apical and midventricular transient left ventricular dysfunction syndrome (Tako-Tsubo cardiomyopathy): frequency, mechanisms, and prognosis. Chest 2007;132:809–16.

7. Lyon AR, Rees PSC, Prasad S, Poole-Wilson PA, Harding SE. Stress (Takotsubo) cardiomyopathy—a novel pathophysiological hypothesis to explain catecholamine-induced acute myocardial stunning. Nat Clin Pr Cardiovasc Med 2008;5:22–9.

8. Tornvall P, Collste O, Ehrenborg E, Järnbert-Petterson H. A case-control study of risk markers and mortality in takotsubo stress cardiomyopathy. J Am Coll Cardiol 2016;67:1931–6.

9. Tsuchihashi K, Ueshima K, Uchida T, et al. Transient left ventricular apical ballooning without coronary artery stenosis: a novel heart syndrome mimicking acute myocardial infarction. J Am Coll Cardiol 2001;38:11–8.

10. Templin C, Ghadri JR, Diekmann J, et al. Clinical features and outcomes of takotsubo (stress) cardiomyopathy. N Engl J Med 2015;373:929–38.

11. Lyon AR, Bossone E, Schneider B, et al. Current state of knowledge on Takotsubo syndrome: a position statement from the Taskforce on Takotsubo Syndrome of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2016;18:8–27.

12. Bybee K, Kara T, Prasad A, Lerman A, Barsness GW, Wright RS. Systematic review: transient left ventricular apical ballooning: a syndrome that mimics ST-segment elevation myocardial infarction. Ann Intern Med 2004;141:858–65.

13. Ghadri J-R, Wittstein IS, Prasad A, et al. International expert consensus document on takotsubo syndrome (part I): clinical characteristics, diagnostic criteria, and pathophysiology. Eur Hear J 2018;39:2032–46.

14. Ghadri J-R, Wittstein IS, Prasad A, et al. International expert consensus document on takotsubo syndrome (part II): diagnostic workup, outcome and management. Eur Hear J 2018;39:2047–62.

15. Weintraub BM, McHenry LC. Cardiac abnormalities in subarachnoid hemorrhage: a resume. Stroke 1974;5:384–92.

16. Samuels MA. The brain-heart connection. Circulation 2007;116:77–84.

17. Pollick C, Cujec B, Parker S, Tator C. Left ventricular wall motion abnormalities in subarachnoid hemorrhage: an echocardiographic study. J Am Coll Cardiol 1988;12:600–5.

18. Suzuki H, Matsumoto Y, Kaneta T, et al. Evidence for brain activation in patients with takotsubo cardiomyopathy. Circ J 2014;78:256–8.

19. Klein C, Hiestand T, Ghadri J-R, Templin C, Jäncke L, Hänggi J. Takotsubo syndrome–predictable from brain imaging data. Sci Rep 2017;7:5434.

20. Biso S, Wongrakpanich S, Agrawal A, Yadlapati S, Kishlyansky M, Figueredo V. A review of neurogenic stunned myocardium. Cardiovasc Psychiatry Neurol 2017;2017:5842182.

21. Del Buono M, Carbone S, Abbate A. Comment on Stiermaier et al. prevalence and prognostic impact of diabetes in takotsubo syndrome: insights from the international, multicenter GEIST Registry. Diabetes Care 2018;41:1084–8.

22. Pelliccia F, Kaski JC, Crea F, Camici PG. Pathophysiology of Takotsubo syndrome. Circulation 2017;135:2426–41.

23. Sonnino C, Van Tassell BW, Toldo S, Del Buono MG, Moeller FG, Abbate A. Lack of soluble circulating cardiodepressant factors in takotsubo cardiomyopathy. Auton Neurosci Basic Clin 2017;208:170–2.

24. Akashi YJ, Goldstein DS, Barbara G, Ueyama T. Takotsubo cardiomyopathy a new form of acute, reversible heart failure. Circulation 2008;118:2754–62.

25. Wittstein I, David RT. Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med 2005;352:539–48.

26. Madhavan M, Borlaug BA, Lerman A, Rihal CS, Prasad A. Stress hormone and circulating biomarker profile of apical ballooning syndrome (Takotsubo cardiomyopathy): insights into the clinical significance of B-type natriuretic peptide and troponin levels. Heart 2009;95:1436–41.

27. Spinelli L, Trimarco V, Di Marino S, Marino M, Iaccarino G, Trimarco B. L41Q polymorphism of the G protein coupled receptor kinase 5 is associated with left ventricular apical ballooning syndrome. Eur J Heart Fail 2010;12:13–6.

28. Galiuto L, De Caterina AR, Porfidia A, et al. Reversible coronary microvascular dysfunction: a common pathogenetic mechanism in apical ballooning or tako-tsubo syndrome. Eur Heart J 2010;31:1319–27.

29. De Caterina AR, Leone AM, Galiuto L, et al. Angiographic assessment of myocardial perfusion in Tako-Tsubo syndrome. Int J Cardiol 2013;168:4717–22.

30. Brinjikji W, El-Sayed AM, Salka S. In-hospital mortality among patients with takotsubo cardiomyopathy:a study of the National Inpatient Sample 2008 to 2009. Am Heart J 2012;164:215–21.

31. Schneider B, Athanasiadis A, Stöllberger C, et al. Gender differences in the manifestation of tako-tsubo cardiomyopathy. Int J Cardiol 2013;166:584–8.

32. Citro R, Rigo F, Previtali M, et al. Differences in clinical features and in-hospital outcomes of older adults with tako-tsubo cardiomyopathy. J Am Geriatr Soc 2012;60:93–8.

33. Vitale C, Mendelsohn ME, Rosano GMC. Gender differences in the cardiovascular effect of sex hormones. Nat Rev Cardiol 2009;6:532–42.

34. Sánchez-Rodríguez MA, Castrejón-Delgado L, Zacarías-Flores M, Arronte-Rosales A, Mendoza-Núñez VM. Quality of life among post-menopausal women due to oxidative stress boosted by dysthymia and anxiety. BMC Womens Health 2017;17:1–9.

35. Bromberger JT, Kravitz HM, Chang YF, Cyranowski JM, Brown C, Matthews KA. Major depression during and after the menopausal transition:the Study of Women’s Health Across the Nation (SWAN). Psychol Med 2011;41:1879–88.

36. Soares CN, Zitek B. Reproductive hormone sensitivity and risk for depression across the female life cycle: a continuum of vulnerability? J Psychiatry Neurosci 2008;33:331–43. 37. Escobar CM, Krajewski SJ, Sandoval-Guzmán T, Voytko M Lou, Rance NE. Neuropeptide Y gene expression is increased in the hypothalamus of older women. J Clin Endocrinol Metab 2004;89:2338–43.

38. Wyon, Yvonne, Spetz Anna-Clara, Theodorsson E. Concentrations of calcitonin generelated peptide and neuropeptide Y in plasma increase during flushes in postmenopausal women. Menopause 2000;7:25–30.

39. Sharkey SW, Windenburg DC, Lesser JR, et al. Natural history and expansive clinical profile of stress (tako-tsubo) cardiomyopathy. J Am Coll Cardiol 2010;55:333–41.

40. Ghadri JR, Sarcon A, Diekmann J, et al. Happy heart syndrome: role of positive emotional stress in takotsubo syndrome. Eur Heart J 2016;37:2823–9.

41. Sharkey SW, Lesser JR, Zenovich AG, et al. Acute and reversible cardiomyopathy provoked by stress in women from the United States. Circulation 2005;111:472–9.

42. Lee VH, Connolly HM, Fulgham JR, Manno EM, Brown RD, Wijdicks EFM. Tako-tsubo cardiomyopathy in aneurysmal subarachnoid hemorrhage:an underappreciated ventricular dysfunction. J Neurosurg 2006;105:264–70.

43. Porto I, Della Bona R, Leo A, et al. Stress cardiomyopathy (tako-tsubo) triggered by nervous system diseases: a systematic review of the reported cases. Int J Cardiol 2013;167:2441–8.

44. Deshmukh A, Kumar G, Pant S, Rihal C, Murugiah K, Mehta JL. Prevalence of Takotsubo cardiomyopathy in the United States. Am Heart J 2012;164:66–71.e1.

45. Summers MR, Prasad A. Takotsubo cardiomyopathy: definition and clinical profile. Heart Fail Clin 2013;9:111–22.

46. Stiermaier T, Santoro F, El-battrawy I, et al. Prevalence and prognostic impact of diabetes in takotsubo syndrome: insights from the international, multicenter GEIST Registry. Diabetes Care 2018;1–5.

47. Madias JE. Low prevalence of diabetes mellitus in patients with Takotsubo syndrome: a plausible “protective” effect with pathophysiologic connotations. Eur Hear Journal Acute Cardiovasc Care 2016;5:164–70.

48. Del Buono M, Carbone S, Abbate A. Diabetes and takotsubo cardiomyopathy: is there a causal link? Diabetes Care 2018;41:e121.

49. Saito N, Suzuki M, Ishii S, et al. Asthmatic attack complicated with takotsubo cardiomyopathy after frequent inhalation of inhaled corticosteroids/long-acting beta2-adrenoceptor agonists. Intern Med 2016;55:1615–20.

50. Pontillo D, Patruno N, Stefanoni R. The takotsubo syndrome and bronchial asthma: the chicken or the egg dilemma. J Cardiovasc Med 2011;12:149.

51. Wheway J, Herzog H, Mackay F. NPY and receptors in immune and inflammatory diseases. Curr Top Med Chem 2007;7:1743–52.

52. Singh A, Agrawal S, Fegley M, Manda Y, Nanda S, Shirani J. Marijuana (cannabis) use is a independent predictor of stress cardiomyopathy in younger men. Circulation 2016;134:A14100.

53. Pacher P, Bátkai S, Knos G. Cardiovascular pharmacology of cannabinoids. Handb Exp Pharmacol 2005;168:599–625.

54. Bakkali-Kassemi L, El Ouezzani S, Magoul R, Merroun I, Lopez-Jurado M, Errami M. Effects of cannabinoids on neuropeptide y and endorphin expression in the rat hypothalamic arcuate nucleus. Br J Nutr 2011;105:654–60.

55. Gamber KM, Macarthur H, Westfall TC. Cannabinoids augment the release of neuropeptide Y in the rat hypothalamus. Neuropharmacology 2005;49:646–52.

56. Bybee KA, Prasad A. Stress-related cardiomyopathy syndromes. Circulation 2008;118:397–409.

57. Woronow D, Suggs C, Levin RL, Diak IL, Kortepeter C. Takotsubo common pathways and SNRI medications. J Am Coll Cardiol HF 2018;6:347–8.

58. Kurisu S, Kihara Y. Tako-tsubo cardiomyopathy:clinical presentation and underlying mechanism. J Cardiol 2012;60:429–37.

59. Haghi D, Fluechter S, Suselbeck T, et al. Takotsubo cardiomyopathy (acute left ventricular apical ballooning syndrome) occurring in the intensive care unit. Intensive Care Med 2006;32:1069–74.

60. Sharkey SW, Maron BJ. Epidemiology and clinical profile of takotsubo cardiomyopathy. Circ J 2014;78:2119–28.

61. Pilgrim TM, Wyss TR. Takotsubo cardiomyopathy or transient left ventricular apical ballooning syndrome: a systematic review. Int J Cardiol 2008;124:283–92.

62. Del Buono MG, O’Quinn MP, Garcia P, et al. Cardiac arrest due to ventricular fibrillation in a 23-year-old woman with broken heart syndrome. Cardiovasc Pathol 2017;30:78–81.

63. Ghadri JR, Cammann VL, Jurisic S, et al. A novel clinical score (InterTAK Diagnostic Score) to differentiate takotsubo syndrome from acute coronary syndrome: results from the International Takotsubo Registry. Eur J Heart Fail 2017;19:1036–42.

64. Kurisu S, Inoue I, Kawagoe T, et al. Time course of electrocardiographic changes in patients with tako-tsubo syndrome: comparison with acute myocardial infarction with minimal enzymatic release. Circ J 2004;68:77–81.

65. Sharkey SW, Lesser JR, Menon M, Parpart M, Maron MS, Maron BJ. Spectrum and significance of electrocardiographic patterns, troponin levels, and thrombolysis in myocardial infarction frame count in patients with stress (tako-tsubo) cardiomyopathy and comparison to those in patients with ST-elevation anterior wall myocardial infarction. Am J Cardiol 2008;101:1723–8.

 

Comentarios

Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

AAIP RNBD
Términos y condiciones de uso | Política de privacidad | Todos los derechos reservados | Copyright 1997-2024